Skip to main content
. 2022 Jan 21;17(1):e0262466. doi: 10.1371/journal.pone.0262466

Fig 2.

Fig 2

Vaccine effectiveness against specific serotypes, (a) 0 dose vs 3 doses, (b) 0 dose vs 2 doses and (c) 0 dose vs 1 dose.